Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Niemann-Pick C1-Like 1 inhibitors for reducing cholesterol absorption
Renshuai Zhang, Wenjing Liu, Jun Zeng, et al.
European Journal of Medicinal Chemistry (2022) Vol. 230, pp. 114111-114111
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics
Yajun Duan, Ke Gong, Suowen Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 238
Insight into structural characteristics of theabrownin from Pingwu Fuzhuan brick tea and its hypolipidemic activity based on the in vivo zebrafish and in vitro lipid digestion and absorption models
Yue Xiao, Huang Yan-ni, Feiwu Long, et al.
Food Chemistry (2022) Vol. 404, pp. 134382-134382
Closed Access | Times Cited: 31
Intelligent delivery system targeting PD-1/PD-L1 pathway for cancer immunotherapy
Ning Liu, Renshuai Zhang, Qiang Shi, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106550-106550
Closed Access | Times Cited: 18
Diosgenin as a substitute for cholesterol alleviates NAFLD by affecting CYP7A1 and NPC1L1-related pathway
Mengyao Yan, Yixin Zhao, Shuli Man, et al.
Phytomedicine (2024) Vol. 125, pp. 155299-155299
Closed Access | Times Cited: 6
Comprehensive molecular mechanisms and clinical therapy in nonalcoholic steatohepatitis: An overview and current perspectives
Mengyao Yan, Shuli Man, Long Ma, et al.
Metabolism (2022) Vol. 134, pp. 155264-155264
Closed Access | Times Cited: 25
Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management
Vasiliki Katsi, Ilias Papakonstantinou, Konstantinos Tsioufis
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11786-11786
Open Access | Times Cited: 16
Advanced function, design and application of skin substitutes for skin regeneration
Miao Zhang, Jiyao Xing, Yingjie Zhong, et al.
Materials Today Bio (2023) Vol. 24, pp. 100918-100918
Open Access | Times Cited: 14
Early hyperlipidemia triggers metabolomic reprogramming with increased SAH, increased acetyl-CoA-cholesterol synthesis, and decreased glycolysis
Keman Xu, Fatma Saaoud, Ying Shao, et al.
Redox Biology (2023) Vol. 64, pp. 102771-102771
Open Access | Times Cited: 11
Bioaccessibility and bioavailability of cardioprotective peptides from fermented milks with specific strains of Limosilactobacillus fermentum after an ex vivo absorption model
Miriam Zambrano-Cervantes, Lilia M. Beltrán‐Barrientos, Miguel Á. Rendón-Rosales, et al.
International Dairy Journal (2025), pp. 106241-106241
Closed Access
Identification of a Novel NPC1L1 Inhibitor from Danshen and Its Role in Nonalcoholic Fatty Liver Disease
Donghai Xia, Xuan Jiang, Xiaomin Xie, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2793-2793
Open Access
Targeting cholesterol metabolism: a promising therapy strategy for cancer
Chun-Lan Dai, Zhixin Qiu, Anqi Wang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Qingre Sanjie Formula alleviates atherosclerosis by promoting LXR-α/ABCG5/G8-mediated reverse cholesterol transport and bile acid synthesis
Xiao Li, Xianglong Huang, K.H. Song, et al.
Phytomedicine (2025), pp. 156691-156691
Closed Access
The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy
Elena Crecca, Gianfranco Di Giuseppe, C Camplone, et al.
Pharmacology & Therapeutics (2025), pp. 108847-108847
Closed Access
The Role of Endothelial Progenitor Cells in Atherosclerosis and Impact of Anti-Lipemic Treatments on Endothelial Repair
Velimir Altabas, Lora Stanka Kirigin Biloš
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2663-2663
Open Access | Times Cited: 17
The potential role and mechanism of circRNAs in foam cell formation
Wujun Chen, Yihui Liu, Ling Li, et al.
Non-coding RNA Research (2023) Vol. 8, Iss. 3, pp. 315-325
Open Access | Times Cited: 9
Comparative treatment of Sulfasalazine+Ezetimibe combination and Sulfasalazine in a rat model with induced colitis
Farrah Rasool Jaafar, Ahmed R. Abu‐Raghif
Journal of Medicine and Life (2023) Vol. 16, Iss. 8, pp. 1165-1169
Open Access | Times Cited: 8
Mechanisms and treatment of atherosclerosis: focus on macrophages
Linlin Zhang, Jiawei Li, Yanhong Kou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Inhibitory Effect of Isoliquiritigenin in Niemann-Pick C1-Like 1-Mediated Cholesterol Uptake
Jun Zeng, Wenjing Liu, Bing Liang, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7494-7494
Open Access | Times Cited: 12
The Metabolic Syndrome: An Overview and Proposed Mechanisms
Fernanda Santos Thomaz, Oliver D. John, Payel Sinha, et al.
Obesities (2024) Vol. 4, Iss. 3, pp. 226-255
Open Access | Times Cited: 2
First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor
Wenjing Liu, Bing Liang, Jun Zeng, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6270-6270
Open Access | Times Cited: 10
Cytochalasans with Inhibitory Activity against NPC1L1 from the Endophytic Fungus Chaetomium nigricolor F5
Chen-Chen Gu, Jun Zeng, Xiao-Ping Peng, et al.
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 5, pp. 3185-3192
Closed Access | Times Cited: 6
Recent advances in the screening methods of NPC1L1 inhibitors
Renshuai Zhang, Wenjing Liu, Jun Zeng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113732-113732
Open Access | Times Cited: 9
In silico discovery of food-derived phytochemicals against asialoglycoprotein receptor 1 for treatment of hypercholesterolemia: Pharmacophore modeling, molecular docking and molecular dynamics simulation approach
Shengyun Gao, Lei Wang, Gen Hua Yue, et al.
Journal of Molecular Graphics and Modelling (2023) Vol. 125, pp. 108614-108614
Closed Access | Times Cited: 5
Impact of Oat (Avena sativa L.) on Metabolic Syndrome and Potential Physiological Mechanisms of Action: A Current Review
Lin Li, Ruiyuan Zhang, Yichen Hu, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 41, pp. 14838-14852
Closed Access | Times Cited: 5
New Fusarin Derivatives from the Marine Algicolous Fungus Penicillium steckii SCSIO41040
Yingying Song, Jianglian She, Weihao Chen, et al.
Marine Drugs (2023) Vol. 21, Iss. 10, pp. 532-532
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top